Our Vision
Our Clinical Trial Unit is dedicated to advancing the treatment landscape for individuals with inflammatory rheumatic conditions. We are a highly skilled, multiprofessional team that collaborates seamlessly in a state-of-the-art facility designed for both clinical and translational research. With extensive experience in designing and conducting a variety of clinical trials—ranging from drug intervention studies to observational and strategic trials, we are committed to conduct our research with the highest standards and to provide innovative care and new treatment options to our patients. Our close partnerships with academic institutions and industry partners along with access to large patient cohorts enhance our ability to perform as a top-level study site or sponsor in multicentric & multinational trials.
What we offer:
- Mutliprofessional team of clinicians, study coordinators, study nurses, biostatisticians, clinical and basic Researchers.
- Multidisciplinary setting embedded in the Vienna General Hospital, one of the largest european hospitals with over 30 different clinical departments.
- Top research facility of the medical university vienna with access to wet labs, biomedical imaging and other basic science core facilities.
- Access to large patient cohorts of different rheumatic conditions visiting our outpatient clinics.
- Experience in designing and conducting phase II - IV clinical trials, non-interventional trials, experimental trials & imaging trials.
Current Clinical Trials
Rheumatoide Arthritis (RA)
Arthralgia Suspicious for Progression to Rheumatoid Arthritis (ASPRA)
Description: Risk evaluation for the development of rheumatoid arthritis in seropositive and seronegative patients with arthralgia.
Status: ongoing recruitment.
Contact: CTU_Rheuma@meduniwien.ac.at ; Phone: 01 40400 54145
Bio-Test (SQUEEZE)
Description: This study investigates the optimization of methotrexate therapy in patients with rheumatoid arthritis through dose escalation and subcutaneous administration. At the same time, innovative biomarkers and treatment adherence are being tested.
Status: ongoing recruitment.
Contact: CTU_Rheuma@meduniwien.ac.at
MethMax (SQUEEZE)
Description: This study investigates the optimization of methotrexate therapy in patients with rheumatoid arthritis through dose escalation and subcutaneous administration. At the same time, innovative biomarkers and treatment adherence are being tested.
Status: ongoing recruitment.
Contact: methmax@meduniwien.ac.at
Check our latest newsletter.
The Rheumatoid Arthritis therapeutic DRUg Monitoring trial (RA-DRUM) (SQUEEZE)
Description: The RA-DRUM study aims to determine whether measuring drug levels (therapeutic drug monitoring - TDM) followed by individual adjustment of dosing intervals can improve the effectiveness of adalimumab in maintaining disease control in patients with rheumatoid arthritis (RA).
Status: recruiting soon.
Contact: CTU_Rheuma@meduniwien.ac.at
Stand: Baldige Rekrutierung.
Psoriatic Arthritis (PsA)
Stop-PsA
Description: Observational trial in Psoriasis patients with Arthralgia to identify risk factors and molecular mechanisms for the development of psoriatic arthritis (PsA).
Status: Ongoing recruitment.
Contact: CTU_Rheuma@meduniwien.ac.at
PsABIOnd
Description: Assessments of guselkumab(Tremfya®) and IL 17 inhibitor therapies in patients with psoriatic arthritis in routine clinical practice; a prospective observational study in cohorts.
Status: Ongoing recruitment.
Contact: CTU_rheuma@meduniwien.ac.at